Camlin Fine Sciences Limited (CAMLINFINE.NS)
NSE · INR · Basic Materials · Specialty Chemicals
₹83.75 (+0.56%) as of
Key statistics
- Market cap
- 16.09B
- Forward P/E
- 10.34
- EPS (TTM)
- -3.00
- Dividend yield
- 0.00%
- 52-week range
- 78.80 – 202.45
- Beta
- 0.68
- Revenue (TTM)
- 18.35B
- Profit margin
- 0.32%
- Analyst target
- ₹152.50
- Volume
- 279.02k
About Camlin Fine Sciences Limited
Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hydroquinone (HQ), Catechol (CAT), Monomethyl Ether of HQ (MEHQ), tert butylcatechol (TBC), Guaiacol, and Veratrole; and health and wellness products comprising algae based products, such as Omega 3 fatty acids. It sells its products under the Xtendra, Nasure, Ezential, adorr, Vitafor, Dinamic, and Biosus brands. The company's products are used in food and beverage, pet food and rendering, animal nutrition, petrochemical, nutrition and health, biofuel, agrochemical, pharmaceutical, polymers, fragrance and flavor, and dyes and pigments industries. The company was formerly known as Camlin Fine Chemicals Ltd. and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Headquarters
- Mumbai, India
- Employees
- 674
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.